Perbak Capital Partners LLP Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001968437
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 31 positions · Total reported value $142.48M · Top-10 concentration 75.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 75.6% · 178 new · 19 cut · 103 exited
Active Share (vs S&P 500): 90.5% · vs QQQ: 96.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q4 2025 → Q1 2026): +1.7% · vs SPY +6.4% · Prev Value $327.73M — last quarter positions weighted by this quarter price moves · ranking
In its Q3 2024 13F filing, Perbak Capital Partners LLP disclosed 31 equity positions with a combined reported value of $142.48M. The filing implies a focused portfolio: its ten largest positions account for 75.0% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q3 2024 were XLI ($37.32M), SPY ($21.14M), ICLN ($13.68M). By sector, the heaviest allocations are Health Care 13.4%, Consumer Discretionary 8.5%. Versus the prior quarter, allocation shifted toward Other (+10.0pp), Consumer Discretionary (+1.0pp) and away from Health Care (-1.5pp), Technology (-1.9pp).
Versus the prior quarter, Perbak Capital Partners LLP opened 178 new positions, trimmed 19 and fully exited 103, a turnover rate of 75.6% of positions. The portfolio's overlap with the prior quarter was 51% of names.
The largest new positions opened in Q3 2024 were CVNA ($2.60M), EMR ($488.56K).
Of the 103 positions fully exited versus the prior quarter, the largest were XLP ($23.34M), MMM ($10.57M), DKNG ($6.84M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- CVNA CARVANA CO · $2.60M
- EMR EMERSON ELEC CO · $488.56K
Fully Exited (vs previous quarter)
- XLP SELECT SECTOR SPDR TR · prev qtr: $23.34M · history
- MMM 3M CO · prev qtr: $10.57M
- DKNG DRAFTKINGS INC NEW · prev qtr: $6.84M · history
- GM GENERAL MTRS CO · prev qtr: $6.09M
- IDXX IDEXX LABS INC · prev qtr: $4.85M
- ELAN ELANCO ANIMAL HEALTH INC · prev qtr: $4.79M
- HPQ HP INC · prev qtr: $3.92M
- WCN WASTE CONNECTIONS INC · prev qtr: $3.45M
Insider Transactions (Form 4)
Latest Perbak Capital Partners LLP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Perbak Capital Partners LLP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q1 2026) lists 294 positions worth $406.38M in total. HoldingsHub carries 9 quarters of its filings (Q1 2024–Q1 2026).
Portfolio Structure
- 294 positions · $406.38M reported value (Q1 2026)
- Top 10 holdings = 44.5% of reported value
- Largest position: XLI (SELECT SECTOR SPDR TR) at 18.4%
- Average position size: $1.38M
Sector Tilt
- Consumer Discretionary 13.9%
- Industrials 13.7%
- Information Technology 8.4%
- (classified holdings cover 53% of value)
Quarterly Activity
- Q1 2026: 178 new, 97 added, 19 reduced, 103 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
275.53K | $37.32M | 26.19% | Add | |
| 2 |
|
36.84K | $21.14M | 14.83% | Reduce | |
| 3 |
|
931.33K | $13.68M | 9.60% | Add | |
| 4 |
|
152.92K | $9.94M | 6.98% | Reduce | |
| 5 |
|
34.05K | $6.82M | 4.79% | Reduce | |
| 6 |
|
18.70K | $3.86M | 2.71% | Reduce | |
| 7 |
|
10.85K | $3.74M | 2.62% | Add | |
| 8 |
|
10.34K | $3.58M | 2.51% | Add | |
| 9 |
|
15.23K | $3.36M | 2.36% | Reduce | |
| 10 |
|
5.75K | $3.36M | 2.36% | Add | |
| 11 |
|
290.35K | $3.07M | 2.15% | Reduce | |
| 12 |
|
67.86K | $3.05M | 2.14% | Reduce | |
| 13 |
|
5.74K | $2.99M | 2.10% | Add | |
| 14 |
|
19.59K | $2.74M | 1.92% | Add | |
| 15 |
|
17.70K | $2.73M | 1.91% | Reduce | |
| 16 |
|
14.96K | $2.60M | 1.83% | New | |
| 17 |
|
41.40K | $2.43M | 1.70% | Reduce | |
| 18 |
|
6.55K | $1.99M | 1.40% | Reduce | |
| 19 |
|
7.94K | $1.82M | 1.28% | Reduce | |
| 20 |
|
82.09K | $1.81M | 1.27% | Reduce | |
| 21 |
|
3.12K | $1.34M | 0.94% | Reduce | |
| 22 |
|
17.35K | $1.25M | 0.88% | Reduce | |
| 23 |
|
21.01K | $1.21M | 0.85% | Reduce | |
| 24 |
|
6.26K | $1.04M | 0.73% | Reduce | |
| 25 |
|
9.75K | $1.01M | 0.71% | Reduce | |
| 26 |
|
2.24K | $909.18K | 0.64% | Reduce | |
| 27 |
|
9.27K | $896.24K | 0.63% | Reduce | |
| 28 |
|
5.66K | $813.88K | 0.57% | Reduce | |
| 29 |
|
2.61K | $779.07K | 0.55% | Reduce | |
| 30 |
|
5.94K | $731.09K | 0.51% | Reduce | |
| 31 |
|
4.47K | $488.56K | 0.34% | New | |
FAQ
What did Perbak Capital Partners LLP buy in 2024-Q3?
In its 2024-Q3 13F filing, Perbak Capital Partners LLP reported 31 equity positions worth $142.48M in aggregate; its largest disclosed positions were XLI ($37.32M), SPY ($21.14M), ICLN ($13.68M).
How large is Perbak Capital Partners LLP's portfolio?
Perbak Capital Partners LLP reported $142.48M of long equity holdings across 31 positions as of 2024-Q3. Top-10 holdings account for 75.0% of reported value.
What is Perbak Capital Partners LLP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.